Cohance Lifesciences Ltd header image

Cohance Lifesciences Ltd

543064

Equity

ISIN INE03QK01018 / Valor 46346459

Bombay Stock Exchange Ltd. (Mumbai) (2026-09-04)
INR 456.55-0.78%

Cohance Lifesciences Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Cohance Lifesciences Ltd is an India-based pharmaceutical company that operates as a contract development and manufacturing organization (CDMO), focusing on the development and commercial manufacture of small-molecule active pharmaceutical ingredients (APIs), intermediates and finished dosage forms. The firm provides process development, custom synthesis, scale‑up and commercial production services for domestic and export customers, positioning itself to support pharmaceutical companies through the transition from laboratory-scale chemistry to regulated commercial manufacturing. Its business is driven by contract manufacturing revenue, product sales and development fees, with competitive differentiation depending on technical know‑how, cost‑efficient production and compliance with regulatory quality standards in target markets.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-49.3%1Y
-10.1%3Y
-13.0%5Y

Performance

50.0%1Y
41.2%3Y
36.8%5Y

Volatility

Market cap

1850 M

Market cap (USD)

Daily traded volume (Shares)

34,569

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Haemonetics Corp
Haemonetics Corp Haemonetics Corp Valor: 937449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 102.92
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.76%USD 158.63
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Valor: 2676862
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.13%SEK 454.80
Indivior PLC
Indivior PLC Indivior PLC Valor: 121550831
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.35%GBP 25.85
Vitrolife AB
Vitrolife AB Vitrolife AB Valor: 41707777
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.50%SEK 95.00
Camurus AB
Camurus AB Camurus AB Valor: 30510553
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.17%SEK 587.00
DBV Technologies SA
DBV Technologies SA DBV Technologies SA Valor: 2857349
starstarstarstarstar